| For: | Imajo K, Tetlow L, Dennis A, Shumbayawonda E, Mouchti S, Kendall TJ, Fryer E, Yamanaka S, Honda Y, Kessoku T, Ogawa Y, Yoneda M, Saito S, Kelly C, Kelly MD, Banerjee R, Nakajima A. Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort. World J Gastroenterol 2021; 27(7): 609-623 [PMID: 33642832 DOI: 10.3748/wjg.v27.i7.609] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i7/609.htm |
| Number | Citing Articles |
| 1 |
Anna Di Bartolomeo, Jacob George. Metabolic Steatotic Liver Disease. 2024; doi: 10.1016/B978-0-323-99649-5.00016-9
|
| 2 |
T. Waddell, A. Namburete, P. Duckworth, A. Fichera, A. Telford, H. Thomaides-Brears, D. J. Cuthbertson, M. Brady. Poor glycaemic control and ectopic fat deposition mediates the increased risk of non-alcoholic steatohepatitis in high-risk populations with type 2 diabetes: Insights from Bayesian-network modelling. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1063882
|
| 3 |
G. Craig Wood, Anthony Hoovler, Rakesh Luthra, Christopher D. Still, Hamzah Shariff, Matthew Still, Jonathan Hayes, Peter Benotti, Chioma Uzoigwe. Noninvasive identification of metabolic dysfunction–associated steatohepatitis (INFORM MASH): a retrospective cohort and disease modeling study. Expert Review of Gastroenterology & Hepatology 2025; 19(4) doi: 10.1080/17474124.2025.2477249
|
| 4 |
Alexandru Popa, Felix Bende, Roxana Șirli, Alina Popescu, Victor Bâldea, Raluca Lupușoru, Radu Cotrău, Renata Fofiu, Camelia Foncea, Ioan Sporea. Quantification of Liver Fibrosis, Steatosis, and Viscosity Using Multiparametric Ultrasound in Patients with Non-Alcoholic Liver Disease: A “Real-Life” Cohort Study. Diagnostics 2021; 11(5) doi: 10.3390/diagnostics11050783
|
| 5 |
Franziska Lobig, Dhinagar Subramanian, Michael Blankenburg, Ankur Sharma, Archana Variyar, Oisin Butler. To pay or not to pay for artificial intelligence applications in radiology. npj Digital Medicine 2023; 6(1) doi: 10.1038/s41746-023-00861-4
|
| 6 |
Fernando Bril. Chronic Complications of Diabetes Mellitus. 2024; doi: 10.1016/B978-0-323-88426-6.00017-8
|
| 7 |
Dylan Windell, Alastair Magness, Cayden Beyer, Helena Thomaides Brears, Sarah Larkin, Kezia Hobson, Paul Aljabar, Kenneth Fleming, Eve Fryer, Timothy James Kendall, Reema Kainth, Phil Wakefield, Caitlin Rose Langford, Pierre Bedossa, Robert Goldin. AI portal tract detection and characterisation for a regional analysis of steatosis and inflammation in MASLD, MASH and AIH. Journal of Clinical Pathology 2026; 79(3) doi: 10.1136/jcp-2025-210311
|
| 8 |
Felix Pablo Widmann, Steffen P. Häseli, Jakob Schattenfroh, Jan Bieling, Noah Jaitner, Marion Muche, Tobias Puengel, Frank Tacke, Patrick Asbach, Dominik Geisel, Bernhard Gebauer, Ingolf Sack, Rolf Reiter. Current Evidence on MR Elastography in Metabolic Dysfunction-Associated Steatohepatitis: A Scoping Review. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 2026; doi: 10.1055/a-2807-9946
|
| 9 |
Hong Chang Tan, Elizabeth Shumbayawonda, Cayden Beyer, Lionel Tim-Ee Cheng, Albert Low, Chin Hong Lim, Alvin Eng, Weng Hoong Chan, Phong Ching Lee, Mei Fang Tay, Stella Kin, Jason Pik Eu Chang, Yong Mong Bee, George Boon Bee Goh, Jun Zhao. Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Elastography to Evaluate the Early Effects of Bariatric Surgery on Nonalcoholic Fatty Liver Disease. International Journal of Biomedical Imaging 2023; 2023 doi: 10.1155/2023/4228321
|
| 10 |
Lija James, Charlie Diamond, Hussein Al-Mossawi, Anneli Andersson, Prashant Pandya, Elizabeth Shumbayawonda, Leila Izadi Firouzabadi, Lily Watson, Laura J Savage, Helena Thomaides-Brears, Rajarshi Banerjee, Laura C Coates. High prevalence of MASLD in psoriasis and psoriatic arthritis assessed with multiparametric magnetic resonance imaging. Rheumatology 2025; 64(11) doi: 10.1093/rheumatology/keaf344
|
| 11 |
Deniz Gul, Michael Pavlides. Imaging Biomarkers in Metabolic Dysfunction Associated Steatotic Liver Disease. Current Hepatology Reports 2025; 24(1) doi: 10.1007/s11901-025-00711-9
|
| 12 |
Minsun Kwak, Abdelrahman M. Attia, Mohammad Saeid Rezaee-Zavareh, Yufeng Wang, Lixia Wang, Walid S. Ayoub, Alexandar Kuo, Paul Martin, Hirsh D. Trivedi, Aarshi Vipani, Yun Wang, Stephen Pandol, Debiao Li, Shelly C. Lu, Hyun-seok Kim, Ju Dong Yang. Refined liver MRI-derived cT1 thresholds capturing hepatic fat fraction enhance mortality risk prediction. JHEP Reports 2026; doi: 10.1016/j.jhepr.2026.101927
|
| 13 |
Rebecca Bresnahan, Rui Duarte, James Mahon, Sophie Beale, Marty Chaplin, Devarshi Bhattacharyya, Rachel Houten, Katherine Edwards, Sarah Nevitt, Michelle Maden, Angela Boland. Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation
. Health Technology Assessment 2023; doi: 10.3310/KGJU3398
|
| 14 |
Xing Xia, Jian He, Yong Wen, Yao Liang, Meihua Yang, Yue Pan, Fangyan Li, Zhaoshu Huang, Pinggui Lei. Construction of a classification model for liver fibrosis in MAFLD based on multiparametric MRI radiomics and machine learning: A rat study. Medical Physics 2026; 53(5) doi: 10.1002/mp.70476
|
| 15 |
Osama Alzoubi, Ahmad Arar, Viraj Singh, Sukru M. Erturk, Ferenc Mozes, Michael Pavlides. MRI in liver cirrhosis. Portal Hypertension & Cirrhosis 2022; 1(1) doi: 10.1002/poh2.6
|
| 16 |
James Neuberger, Owen Cain. The Need for Alternatives to Liver Biopsies: Non-Invasive Analytics and Diagnostics. Hepatic Medicine: Evidence and Research 2021; doi: 10.2147/HMER.S278076
|
| 17 |
Kento Imajo, Hidenori Toyoda, Satoshi Yasuda, Yasuaki Suzuki, Katsutoshi Sugimoto, Hidekatsu Kuroda, Tomoyuki Akita, Junko Tanaka, Yutaka Yasui, Nobuharu Tamaki, Masayuki Kurosaki, Namiki Izumi, Atsushi Nakajima, Takashi Kumada. Utility of Ultrasound-Guided Attenuation Parameter for Grading Steatosis With Reference to MRI-PDFF in a Large Cohort. Clinical Gastroenterology and Hepatology 2022; 20(11) doi: 10.1016/j.cgh.2021.11.003
|
| 18 |
Naim Alkhouri, Mukesh Harisinghani. Letter to the Editor: Comparing quantitative MRI technologies in steatotic liver disease. Hepatology 2024; 79(4) doi: 10.1097/HEP.0000000000000676
|
| 19 |
Ting Duan, Han-Yu Jiang, Wen-Wu Ling, Bin Song. Noninvasive imaging of hepatic dysfunction: A state-of-the-art review. World Journal of Gastroenterology 2022; 28(16): 1625-1640 doi: 10.3748/wjg.v28.i16.1625
|
| 20 |
Consolato M. Sergi. NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review. International Journal of Molecular Sciences 2024; 25(15) doi: 10.3390/ijms25158462
|
| 21 |
Jennifer Cathcart, Rachael Barrett, James S. Bowness, Ashis Mukhopadhya, Ruairi Lynch, John F. Dillon. Accuracy of Non‐Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD: A Systematic Review. Liver International 2025; 45(4) doi: 10.1111/liv.16127
|
| 22 |
Kento Imajo, Yusuke Saigusa, Takashi Kobayashi, Koki Nagai, Shinya Nishida, Nobuyoshi Kawamura, Hiroyoshi Doi, Michihiro Iwaki, Asako Nogami, Yasushi Honda, Takaomi Kessoku, Yuji Ogawa, Hiroyuki Kirikoshi, Shigehiro Kokubu, Daisuke Utsunomiya, Hirokazu Takahashi, Shinichi Aishima, Yoshio Sumida, Satoru Saito, Masato Yoneda, Andrea Dennis, Stella Kin, Anneli Andersson, Atsushi Nakajima. Head-to-head comparison among FAST, MAST, and multiparametric MRI-based new score in diagnosing at-risk MASH. European Radiology 2024; 35(6) doi: 10.1007/s00330-024-11215-3
|
| 23 |
Daisuke Morimoto-Ishikawa. 18. Quantitative Magnetic Resonance Imaging Technique in Abdomen: Current Status and Future Prospects. Japanese Journal of Radiological Technology 2023; 79(7) doi: 10.6009/jjrt.2023-2224
|
| 24 |
Meaghan M. Phipps, Tatiana Hage, Emily Truong, Ju Dong Yang, Lauren Nicolosi, Andrea Dennis, Elizabeth Shumbayawonda, Prashant Pandya, Julia Wattacheril. Multiparametric magnetic resonance imaging may improve detection of patients with at-risk MASH: Real world experience in hepatology clinics. Digestive and Liver Disease 2025; 57(8) doi: 10.1016/j.dld.2025.05.023
|
| 25 |
Carolina Rio Bartulos, Thomas J. Vogl, Philipp Wiggermann. Neue MRT-Verfahren zur NASH-Diagnostik. Gastro-News 2023; 10(6) doi: 10.1007/s15036-023-3332-x
|
| 26 |
Elizabeth Shumbayawonda, Marika French, Jane Elizabeth Carolan, Cayden Beyer, Paula Lorgelly, Dimitar Tonev, Rajarshi Banerjee, Michael H. Miller, Christopher D. Byrne, Janisha Patel, Saima Ajaz, Kosh Agarwal, Johanna Backhus, Minneke J. Coenraad, Jelte J. Schaapman, Andrew Fraser, Miguel Castelo Branco, Stephen Barclay, Matthias M. Dollinger, Daniel J. Cuthbertson, Daniel Forton, Hildo J. Lamb. Utility and cost-effectiveness of LiverMultiScan for MASLD diagnosis: a real-world multi-national randomised clinical trial. Communications Medicine 2025; 5(1) doi: 10.1038/s43856-025-00796-9
|
| 27 |
Jiahui Li, Alina M. Allen, Meng Yin. Reply: Comparing quantitative MRI technologies in steatotic liver disease. Hepatology 2024; 79(4) doi: 10.1097/HEP.0000000000000677
|
| 28 |
Kamil Janowski, Elizabeth Shumbayawonda, Lin Cheng, Caitlin Langford, Andrea Dennis, Matt Kelly, Maciej Pronicki, Wieslawa Grajkowska, Malgorzata Wozniak, Piotr Pawliszak, Sylwia Chełstowska, Elzbieta Jurkiewicz, Rajarshi Banerjee, Piotr Socha. Quantitative multiparametric MRI as a non-invasive stratification tool in children and adolescents with autoimmune liver disease. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-94754-9
|
| 29 |
Kento Imajo, Hidenori Toyoda, Satoshi Yasuda, Hidekatsu Kuroda, Masato Yoneda, Atsushi Nakajima, Takashi Kumada. Direct comparison of ultrasound-guided attenuation parameter and controlled attenuation parameter for steatosis using MRI-based proton density fat fraction as a reference. Ultrasonography 2026; 45(1) doi: 10.14366/usg.25127
|
| 30 |
Kamil Janowski, Elizabeth Shumbayawonda, Matt Kelly, Carlos Ferreira, Maciej Pronicki, Wieslawa Grajkowska, Magdalena Naorniakowska, Piotr Pawliszak, Sylwia Chełstowska, Elżbieta Jurkiewicz, Rajarshi Banerjee, Piotr Socha. Quantitative MR in Paediatric Patients with Wilson Disease: A Case Series Review. Children 2022; 9(5) doi: 10.3390/children9050613
|
| 31 |
Michael Ndaa, Prashant K. Pandya, Jordan Swensson, Niharika Samala, Saima Ajaz, Deepak Joshi, Walid S. Ayoub, Fatih Akisik. Reliable Monitoring of Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease Using Imaging: A Systematic Literature Review and Meta-Analysis on Measurement Repeatability. Endocrine Practice 2026; 32(2) doi: 10.1016/j.eprac.2025.09.205
|
| 32 |
Marcelo Kugelmas, Mazen Noureddin, Nadege Gunn, Kimberly Brown, Zobair Younossi, Manal Abdelmalek, Naim Alkhouri. The use of current knowledge and non‐invasive testing modalities for predicting at‐risk non‐alcoholic steatohepatitis and assessing fibrosis. Liver International 2023; 43(5) doi: 10.1111/liv.15555
|
| 33 |
Benito de Celis Alonso, Elizabeth Shumbayawonda, Cayden Beyer, Silvia Hidalgo-Tobon, Briseida López-Martínez, Pilar Dies-Suarez, Miguel Klunder-Klunder, América Liliana Miranda-Lora, Eduardo Barragán Pérez, Helena Thomaides-Brears, Rajarshi Banerjee, E. Louise Thomas, Jimmy D. Bell, Po-Wah So. Liver magnetic resonance imaging, non-alcoholic fatty liver disease and metabolic syndrome risk in pre-pubertal Mexican boys. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-77307-8
|
| 34 |
Kento Imajo, Yusuke Saigusa, Takashi Kobayashi, Koki Nagai, Shinya Nishida, Nobuyoshi Kawamura, Hiroyoshi Doi, Michihiro Iwaki, Asako Nogami, Yasushi Honda, Takaomi Kessoku, Yuji Ogawa, Hiroyuki Kirikoshi, Satoshi Yasuda, Hidenori Toyoda, Hideki Hayashi, Shigehiro Kokubu, Daisuke Utsunomiya, Hirokazu Takahashi, Shinichi Aishima, Beom Kyung Kim, Nobuharu Tamaki, Satoru Saito, Masato Yoneda, Rohit Loomba, Atsushi Nakajima. M‐PAST score is better than MAST score for the diagnosis of active fibrotic nonalcoholic steatohepatitis. Hepatology Research 2023; 53(9) doi: 10.1111/hepr.13927
|
| 35 |
Weijie Jiao, Huihui Zhou, Jun Zhang, Yuan Yuan, Junci Wei, Xue Gong, Yuanyuan Sun, Lin Sang, Ming Yu. Mesoporous silica nanoparticles as sensitizers: A novel approach to enhancing shear wave elastography in liver stiffness measurement. Biomaterials Advances 2025; 169 doi: 10.1016/j.bioadv.2024.214171
|
| 36 |
Jamerson Silva de Albuquerque Júnior, Ana Carolina Cardoso, José Araújo dos Santos Júnior, Patrícia Spara Gadelha, Romilton dos Santos Amaral, Zahily Herrero Fernández, Josineide Marques do Nascimento Santos. Quantitative ultrasound for hepatic fat assessment: physical principles, signal processing, and technological advances – a scoping review. Biomedical Physics & Engineering Express 2026; 12(3) doi: 10.1088/2057-1976/ae7378
|
| 37 |
Kevin Kim-Jun Teh, Jason Pik-Eu Chang, George Boon-Bee Goh. Comprehensive Guide to Hepatitis Advances. 2023; doi: 10.1016/B978-0-323-98368-6.00014-8
|
| 38 |
Rita Basu, Mazen Noureddin, Jeanne M. Clark. Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers. Mayo Clinic Proceedings 2022; 97(9) doi: 10.1016/j.mayocp.2022.04.005
|
| 39 |
Anneli Andersson, Matt Kelly, Kento Imajo, Atsushi Nakajima, Jonathan A. Fallowfield, Gideon Hirschfield, Michael Pavlides, Arun J. Sanyal, Mazen Noureddin, Rajarshi Banerjee, Andrea Dennis, Stephen Harrison. Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis. Clinical Gastroenterology and Hepatology 2022; 20(11) doi: 10.1016/j.cgh.2021.09.041
|
| 40 |
Richard K. Sterling, Andres Duarte-Rojo, Keyur Patel, Sumeet K. Asrani, Mouaz Alsawas, Jonathan A. Dranoff, Maria Isabel Fiel, M. Hassan Murad, Daniel H. Leung, Deborah Levine, Tamar H. Taddei, Bachir Taouli, Don C. Rockey. AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology 2025; 81(2) doi: 10.1097/HEP.0000000000000843
|
| 41 |
Anneli Andersson, Rohit Loomba, Cayden Beyer, Sofia Mouchti, Raj Vuppalanchi, Mukesh Harisinghani, Saima Ajaz, Amreen Dinani, Amitava Banerjee, Mark Muthiah, Andrea Dennis, Michele Pansini. Change in cT1 Following Interventions in MASLD: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology 2026; 24(2) doi: 10.1016/j.cgh.2025.03.003
|
| 42 |
Shuang Zheng, Kan He, Lei Zhang, Mingyang Li, Huimao Zhang, Pujun Gao. Conventional and artificial intelligence-based computed tomography and magnetic resonance imaging quantitative techniques for non-invasive liver fibrosis staging. European Journal of Radiology 2023; 165 doi: 10.1016/j.ejrad.2023.110912
|
| 43 |
Shi Qi, Xiaodie Wei, Jinhan Zhao, Xinhuan Wei, Haiqing Guo, Jingxian Hu, Qiqige WuYun, Calvin Q. Pan, Nengwei Zhang, Jing Zhang. Performance of MAST, FAST, and MEFIB in predicting metabolic dysfunction‐associated steatohepatitis. Journal of Gastroenterology and Hepatology 2024; 39(8) doi: 10.1111/jgh.16589
|
| 44 |
Ernst Michael Jung, Isabel Wiesinger, Ulrich Kaiser, Friedrich Jung. Initial experiences with dynamic, quality indicator-based multimodal tissue analysis (M-Ref) with parallel assessment of viscosity and shear wave elastography in liver parenchyma alterations. Clinical Hemorheology and Microcirculation 2024; 88(4) doi: 10.3233/CH-248111
|
| 45 |
Marian A. Troelstra, Julia J. Witjes, Anne‐Marieke van Dijk, Anne L. Mak, Oliver Gurney‐Champion, Jurgen H. Runge, Diona Zwirs, Daniela Stols‐Gonçalves, Aelko H. Zwinderman, Marije ten Wolde, Houshang Monajemi, Sandjai Ramsoekh, Ralph Sinkus, Otto M. van Delden, Ulrich H. Beuers, Joanne Verheij, Max Nieuwdorp, Aart J. Nederveen, Adriaan G. Holleboom. Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD‐NASH Cohort. Journal of Magnetic Resonance Imaging 2021; 54(6) doi: 10.1002/jmri.27703
|
| 46 |
Jiahui Li, Xin Lu, Zheng Zhu, Kyle J. Kalutkiewicz, Taofic Mounajjed, Terry M. Therneau, Sudhakar K. Venkatesh, Yi Sui, Kevin J. Glaser, Safa Hoodeshenas, Armando Manduca, Vijay H. Shah, Richard L. Ehman, Alina M. Allen, Meng Yin. Head-to-head comparison of magnetic resonance elastography-based liver stiffness, fat fraction, and T1 relaxation time in identifying at-risk NASH. Hepatology 2023; 78(4) doi: 10.1097/HEP.0000000000000417
|
| 47 |
Nikolaos Panagiotopoulos, Tanya Wolfson, David T. Harris, Danielle Batakis, Rashmi Agni, Lael Ceriani, Yesenia Covarrubias, Gavin Hamilton, Michael S. Middleton, Vitor F. Martins, Anthony C. Gamst, Thekla H. Oechtering, Ryan Sappenfield, Santiago Horgan, Eduardo Grunvald, Luke M. Funk, Garth R. Jacobsen, Anne O. Lidor, James A. Goodman, Sami B. Khoury, Claude B. Sirlin, Scott B. Reeder. Proton density fat fraction for diagnosis of metabolic dysfunction–associated steatotic liver disease. Hepatology 2026; 83(1) doi: 10.1097/HEP.0000000000001318
|
| 48 |
Monica A. Tincopa, Rohit Loomba. Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease. Seminars in Liver Disease 2024; 44(03) doi: 10.1055/s-0044-1788277
|